Back to BlackRock, Inc. BlackRock, Inc.

RIGLRIGL
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in RIGEL PHARMACEUTICALS INC

BlackRock, Inc. holds 1.9M shares of RIGL (RIGEL PHARMACEUTICALS INC), worth $75.9M as of 2026-Q2. The position was increased (+9.7% shares). RIGL represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$75.9M

Current Shares

1.9M

Total Value Change

+$46.5M

Total Shares Change

+191,711

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.9M
+9.7%
$75.9M0.0%$39.12
33
2026-Q1
Increased
1.8M
+6.3%
$47.8M0.0%$33.02
31
2025-Q4
Decreased
1.7M
-3.5%
$71.3M0.0%$42.83
0
2025-Q3
Increased
1.7M
+6.1%
$48.9M0.0%$28.75
31
2025-Q2
Decreased
1.6M
-6.2%
$30.5M0.0%$19.48
0
2025-Q1
Decreased
1.7M
-0.9%
$31.2M0.0%$17.88
0
2024-Q4
New
1.7M
-
$29.4M0.0%$16.47
40

Other major holders of RIGL: STATE STREET CORP, VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used